Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Molecular Pharming for Low and Middle Income Countries

Murad, S; Fuller, S; Menary, J; Moore, C; Pinneh, E; Szeto, T; Hitzeroth, I; Freire, M; Taychakhoonavudh, S; Phoolcharoen, W; et al. Murad, S; Fuller, S; Menary, J; Moore, C; Pinneh, E; Szeto, T; Hitzeroth, I; Freire, M; Taychakhoonavudh, S; Phoolcharoen, W; Ma, J K-C (2020) Molecular Pharming for Low and Middle Income Countries. CURRENT OPINION IN BIOTECHNOLOGY, 61. pp. 53-59. ISSN 0958-1669
SGUL Authors: Ma, Julian

[img] Microsoft Word (.docx) Accepted Version
Restricted to Repository staff only until 18 November 2020.
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (37kB)


Interest in applications and benefits that Molecular Pharming might offer to Low and Middle Income Countries has always been a potent driver for the research discipline, and a major reason why many scientists entered the field. Although enthusiasm remains high, the reality is that such game-changing innovation would always take longer than traditional uptake of new technology in developed countries, and be complicated by external factors beyond technical feasibility. Excitingly, signs of increasing interest by LMICS in Molecular Pharming are now emerging. Here, three case studies from Thailand, South Africa and Brazil are used to identify some of the key issues when a new investment into Molecular Pharming manufacturing capacity is under consideration. At present, academic research is not necessarily addressing these issues. Only by understanding the concerns, can members of the academic community contribute to helping the development of Molecular Pharming for LMICs by focusing their research efforts appropriately.

Item Type: Article
Additional Information: © 2019. This manuscript version is made available under the CC-BY-NC-ND 4.0 license
Keywords: 06 Biological Sciences, 10 Technology, 09 Engineering, Biotechnology
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
ISSN: 0958-1669
February 2020Published
18 November 2019Published Online
14 October 2019Accepted
Publisher License: Creative Commons: Attribution-Noncommercial-No Derivative Works 4.0
Project IDFunderFunder ID
UNSPECIFIEDSir Joseph Hotung Charitable TrustUNSPECIFIED
774078 (Pharma-Factory)European Commission
760331 (Newcotiana)European Commission
Publisher's version:


Item downloaded times since 11 Nov 2019.

Actions (login required)

Edit Item Edit Item